Amarin Corporation plc (ADR)
General ticker "AMRN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.4B (TTM average)
Amarin Corporation plc (ADR) follows the US Stock Market performance with the rate: 42.7%.
Estimated limits based on current volatility of 2.4%: low 14.33$, high 15.03$
Factors to consider:
- Total employees count: 275 (0.0%) as of 2024
- US accounted for 72.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on VASCEPA, Regulatory and compliance, Economic downturns and volatility, Labor/talent shortage/retention, Supply chain disruptions
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.24$, 22.48$]
- 2026-12-31 to 2027-12-31 estimated range: [8.03$, 20.01$]
Financial Metrics affecting the AMRN estimates:
- Positive: with PPE of -275.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 0.15 > -0.65
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 0.07 < Operating cash flow per share per price, % of 0.12
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 68.47 > 64.25
- Negative: negative Net income
Short-term AMRN quotes
Long-term AMRN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $306.91MM | $228.61MM | $182.75MM |
| Operating Expenses | $374.50MM | $320.41MM | $196.69MM |
| Operating Income | $-67.59MM | $-91.80MM | $-13.94MM |
| Non-Operating Income | $13.92MM | $14.60MM | $-27.61MM |
| Interest Expense | $0.01MM | $0.01MM | $0.01MM |
| R&D Expense | $22.22MM | $20.87MM | $19.81MM |
| Income(Loss) | $-53.67MM | $-77.20MM | $-41.55MM |
| Taxes | $5.44MM | $4.98MM | $-2.75MM |
| Profit(Loss)* | $-58.88MM | $-82.18MM | $-77.60MM |
| Stockholders Equity | $552.10MM | $486.18MM | $459.28MM |
| Inventory | $258.62MM | $166.05MM | $195.91MM |
| Assets | $831.68MM | $685.35MM | $670.77MM |
| Operating Cash Flow | $6.88MM | $-31.02MM | $6.74MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-25.52MM | $-45.98MM | $8.85MM |
| Financing Cash Flow | $0.23MM | $-1.44MM | $-2.04MM |
| Earnings Per Share** | $-2.99 | $-4.00 | $-0.19 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.